Scott Terrillion, Sec'y, Chief Compliance & G.C at Cara Therapeutics, Inc. (CARA), sold 12,512 shares at $9.71 ($121K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Open-market sale of $121k CARA by Sec'y, Chief Compliance & G.C. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.71 | 6,256 | $61K | 50.0% |
| 2 | $9.71 | 6,256 | $61K | 50.0% |
| Total | $9.71 avg | 12,512 | $121K | 100% |
| Filing → |
| CARA | SELL | 2024-03-04 | $3K | — | Filing → |
| CARA | SELL | 2024-02-12 | $4K | — | Filing → |
| CARA | SELL | 2023-06-27 | $9K | — | Filing → |